Nongfu Spring Co Ltd (9633)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 41.88 |
|---|---|
| 52-week range | 37.90 – 54.78 |
| Return, 1 month / 3 months | +7.5% / −1.3% |
| Return, 1 year / 3 years | −20.7% / +1.3% |
| Trend | Below its 200-day average |
| RSI (14) | 61 |
| Volatility (1 year) | 32.6% |
| Worst drawdown (1 year) | -29.7% |
| Average daily value traded | 252.62M HKD |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nongfu Spring is a Chinese beverage company based in Hangzhou that bottles natural water drawn from protected sources and sells it under its own brand. It also makes and markets tea drinks, functional beverages and fruit juices, offering them in packaged bottles and cans. Its customers are everyday consumers across China, who buy its drinks through supermarkets, convenience stores, restaurants and other retail outlets. The company manages its own water sources, production plants and distribution to supply those retail channels.
On this site Nongfu Spring Co Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 9633, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nongfu Spring Co Ltd (9633) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 41.88 on 20 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 483 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.7% and over the last three months it fell 1.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.0% | ||
| From 52-week high | -23.3% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.3% | ||
| 6-month return | -6.8% | ||
| 12-month return, skipping the last month | -26.2% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.7% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 252.62M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | +7.5% |
| 3 months | −1.3% |
| 6 months | −6.8% |
| 1 year | −20.7% |
| 3 years | +1.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 41.12 / 43.61 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 May 2026 | HKD 1.1300 |
| 22 May 2025 | HKD 0.8200 |
| 23 May 2024 | HKD 0.8200 |
| 18 May 2023 | HKD 0.7700 |
| 16 Jun 2022 | HKD 0.5297 |
| 29 Jun 2021 | HKD 0.2044 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.